Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe

We measured early 2016/17 season influenza vaccine effectiveness (IVE) against influenza A(H3N2) in Europe using multicentre case control studies at primary care and hospital levels. IVE at primary care level was 44.1%, 46.9% and 23.4% among 0–14, 15–64 and ≥ 65 year-olds, and 25.7% in the influenza...

Descripción completa

Detalles Bibliográficos
Autores principales: Kissling, Esther, Rondy, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2017
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322188/
https://www.ncbi.nlm.nih.gov/pubmed/28230524
http://dx.doi.org/10.2807/1560-7917.ES.2017.22.7.30464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322188/
https://www.ncbi.nlm.nih.gov/pubmed/28230524
http://dx.doi.org/10.2807/1560-7917.ES.2017.22.7.30464

Ejemplares similares